{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 12,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 3
      },
      "2": {
        "core": 1,
        "branch": 3
      },
      "3": {
        "core": 1,
        "branch": 3
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A11 → A10)",
        "prover9_expression": "(requires_black_box_warning(drug_x) -> requires_warning_label(drug_x))",
        "natural": "If drug X requires a black box warning, then drug X requires a warning label."
      },
      {
        "id": "Rule2",
        "formal": "(A12 ∨ (¬(A9 → G) → A11))",
        "prover9_expression": "(fast_track_approval(drug_x) | (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x)))",
        "natural": "Either drug X receives fast track approval, or if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
      },
      {
        "id": "Rule3",
        "formal": "(A13 → G)",
        "prover9_expression": "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
        "natural": "Provided that phase 1 for drug X is complete, drug X is safe for use."
      },
      {
        "id": "Rule4",
        "formal": "(A14 → G)",
        "prover9_expression": "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
        "natural": "Whenever phase 2 for drug X is complete, drug X is safe for use."
      },
      {
        "id": "Rule5",
        "formal": "(A15 → A13)",
        "prover9_expression": "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
        "natural": "If animal testing for drug X is complete, then phase 1 for drug X is complete."
      },
      {
        "id": "Rule6",
        "formal": "(A16 → A14)",
        "prover9_expression": "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
        "natural": "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete."
      },
      {
        "id": "Rule7",
        "formal": "(A17 → (A15 ∨ A16))",
        "prover9_expression": "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
        "natural": "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
      },
      {
        "id": "Rule8",
        "formal": "(A18 → (A15 ∨ A16))",
        "prover9_expression": "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
        "natural": "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
      },
      {
        "id": "Rule9",
        "formal": "(A19 ∨ (A17 ∨ A18))",
        "prover9_expression": "(market_withdrawal(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
        "natural": "Drug X is withdrawn from the market, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
      },
      {
        "id": "Rule10",
        "formal": "(A2 ∨ A3)",
        "prover9_expression": "(rejected(drug_x) | pending_review(drug_x))",
        "natural": "Either drug X is rejected, or drug X is pending review."
      },
      {
        "id": "Rule11",
        "formal": "(A20 ∨ ¬A19)",
        "prover9_expression": "(voluntary_recall(drug_x) | -market_withdrawal(drug_x))",
        "natural": "Drug X is voluntarily recalled, or it is not the case that drug X is withdrawn from the market."
      },
      {
        "id": "Rule12",
        "formal": "(A21 → A22)",
        "prover9_expression": "(regulatory_violation(drug_x) -> fine_imposed(drug_x))",
        "natural": "Provided that drug X has a regulatory violation, a fine is imposed on drug X."
      },
      {
        "id": "Rule13",
        "formal": "(A21 → A24)",
        "prover9_expression": "(regulatory_violation(drug_x) -> criminal_charges(drug_x))",
        "natural": "Whenever drug X has a regulatory violation, criminal charges are filed for drug X."
      },
      {
        "id": "Rule14",
        "formal": "(A21 ∨ (A2 → ¬A1))",
        "prover9_expression": "(regulatory_violation(drug_x) | (rejected(drug_x) -> -approved(drug_x)))",
        "natural": "Drug X has a regulatory violation, or if drug X is rejected, then it is not the case that drug X is approved."
      },
      {
        "id": "Rule15",
        "formal": "(A23 → ¬A22)",
        "prover9_expression": "(license_suspended(drug_x) -> -fine_imposed(drug_x))",
        "natural": "Should the license for drug X be suspended, then it is not the case that a fine is imposed on drug X."
      },
      {
        "id": "Rule16",
        "formal": "(A24 → A23)",
        "prover9_expression": "(criminal_charges(drug_x) -> license_suspended(drug_x))",
        "natural": "If criminal charges are filed for drug X, then the license for drug X is suspended."
      },
      {
        "id": "Rule17",
        "formal": "(A25 → ¬A1)",
        "prover9_expression": "(patent_protected(drug_x) -> -approved(drug_x))",
        "natural": "Assuming drug X is patent protected, then it is not the case that drug X is approved."
      },
      {
        "id": "Rule18",
        "formal": "(A27 → ¬A26)",
        "prover9_expression": "(exclusive_marketing(drug_x) -> -generic_available(drug_x))",
        "natural": "Provided that drug X has exclusive marketing rights, then it is not the case that a generic version of drug X is available."
      },
      {
        "id": "Rule19",
        "formal": "(A28 → (¬A25 → A27))",
        "prover9_expression": "(patent_expired(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
        "natural": "If the patent for drug X has expired, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights."
      },
      {
        "id": "Rule20",
        "formal": "(A29 → (¬A25 → A27))",
        "prover9_expression": "(patent_challenged(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
        "natural": "In the event that the patent for drug X is challenged, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights."
      },
      {
        "id": "Rule21",
        "formal": "(A3 → ¬A1)",
        "prover9_expression": "(pending_review(drug_x) -> -approved(drug_x))",
        "natural": "Should drug X be pending review, then it is not the case that drug X is approved."
      },
      {
        "id": "Rule22",
        "formal": "(A30 → A28)",
        "prover9_expression": "(generic_application_submitted(drug_x) -> patent_expired(drug_x))",
        "natural": "If a generic application for drug X is submitted, then the patent for drug X has expired."
      },
      {
        "id": "Rule23",
        "formal": "(A31 → A29)",
        "prover9_expression": "(biosimilar_application_submitted(drug_x) -> patent_challenged(drug_x))",
        "natural": "Provided that a biosimilar application for drug X is submitted, then the patent for drug X is challenged."
      },
      {
        "id": "Rule24",
        "formal": "(A33 → A32)",
        "prover9_expression": "(price_reduction(drug_x) -> competitive_market_entry(drug_x))",
        "natural": "Whenever the price of drug X is reduced, competitive market entry occurs for drug X."
      },
      {
        "id": "Rule25",
        "formal": "(A33 ∨ A34)",
        "prover9_expression": "(price_reduction(drug_x) | market_share_loss(drug_x))",
        "natural": "The price of drug X is reduced, or drug X experiences market share loss."
      },
      {
        "id": "Rule26",
        "formal": "(A36 ∨ ¬A4)",
        "prover9_expression": "(orphan_drug_status(drug_x) | -requires_clinical_trial(drug_x))",
        "natural": "Drug X has orphan drug status, or it is not the case that drug X requires a clinical trial."
      },
      {
        "id": "Rule27",
        "formal": "(A37 → ¬A36)",
        "prover9_expression": "(rare_disease_indication(drug_x) -> -orphan_drug_status(drug_x))",
        "natural": "If drug X has a rare disease indication, then it is not the case that drug X has orphan drug status."
      },
      {
        "id": "Rule28",
        "formal": "(A37 ∨ A38)",
        "prover9_expression": "(rare_disease_indication(drug_x) | unmet_medical_need(drug_x))",
        "natural": "Either drug X has a rare disease indication, or drug X addresses an unmet medical need."
      },
      {
        "id": "Rule29",
        "formal": "(A38 → ¬A36)",
        "prover9_expression": "(unmet_medical_need(drug_x) -> -orphan_drug_status(drug_x))",
        "natural": "In case drug X addresses an unmet medical need, then it is not the case that drug X has orphan drug status."
      },
      {
        "id": "Rule30",
        "formal": "(A39 → G)",
        "prover9_expression": "(requires_monitoring(drug_x) -> safe_for_use(drug_x))",
        "natural": "Provided that drug X requires monitoring, then drug X is safe for use."
      },
      {
        "id": "Rule31",
        "formal": "(A40 → (A9 → A39))",
        "prover9_expression": "(post_market_surveillance(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
        "natural": "Should drug X be under post-market surveillance, then if drug X has mild side effects, drug X requires monitoring."
      },
      {
        "id": "Rule32",
        "formal": "(A40 ∨ A41)",
        "prover9_expression": "(post_market_surveillance(drug_x) | risk_management_program(drug_x))",
        "natural": "Drug X is under post-market surveillance, or drug X has a risk management program."
      },
      {
        "id": "Rule33",
        "formal": "(A43 → (¬(A9 → G) → A10))",
        "prover9_expression": "(adverse_event_reporting(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
        "natural": "Assuming adverse event reporting is conducted for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
      },
      {
        "id": "Rule34",
        "formal": "(A43 ∨ A44)",
        "prover9_expression": "(adverse_event_reporting(drug_x) | patient_registry(drug_x))",
        "natural": "Adverse event reporting is conducted for drug X, or a patient registry exists for drug X."
      },
      {
        "id": "Rule35",
        "formal": "(A46 ∨ A47)",
        "prover9_expression": "(audit_scheduled(drug_x) | inspection_required(drug_x))",
        "natural": "Either an audit is scheduled for drug X, or an inspection is required for drug X."
      },
      {
        "id": "Rule36",
        "formal": "(A47 → (¬(A44 → (¬(A9 → G) → A10)) → A45))",
        "prover9_expression": "(inspection_required(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
        "natural": "Whenever an inspection is required for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
      },
      {
        "id": "Rule37",
        "formal": "(A48 → (A46 → (¬(A44 → (¬(A9 → G) → A10)) → A45)))",
        "prover9_expression": "(compliance_certified(drug_x) -> (audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))))",
        "natural": "Should drug X be compliance certified, then if an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
      },
      {
        "id": "Rule38",
        "formal": "(A50 → A49)",
        "prover9_expression": "(special_handling(drug_x) -> restricted_distribution(drug_x))",
        "natural": "If drug X requires special handling, then drug X has restricted distribution."
      },
      {
        "id": "Rule39",
        "formal": "(A51 → (¬(A9 → G) → A50))",
        "prover9_expression": "(controlled_substance(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x)))",
        "natural": "Provided that drug X is a controlled substance, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires special handling."
      },
      {
        "id": "Rule40",
        "formal": "(A52 → A54)",
        "prover9_expression": "(prescription_required(drug_x) -> specialist_referral(drug_x))",
        "natural": "If a prescription is required for drug X, then a specialist referral is required for drug X."
      },
      {
        "id": "Rule41",
        "formal": "(A52 → ¬A53)",
        "prover9_expression": "(prescription_required(drug_x) -> -physician_authorization(drug_x))",
        "natural": "In case a prescription is required for drug X, then it is not the case that physician authorization is needed for drug X."
      },
      {
        "id": "Rule42",
        "formal": "(A54 → A53)",
        "prover9_expression": "(specialist_referral(drug_x) -> physician_authorization(drug_x))",
        "natural": "Should a specialist referral be required for drug X, then physician authorization is needed for drug X."
      },
      {
        "id": "Rule43",
        "formal": "(A56 → A58)",
        "prover9_expression": "(quality_control_issue(drug_x) -> batch_recall(drug_x))",
        "natural": "If drug X has a quality control issue, then a batch recall is issued for drug X."
      },
      {
        "id": "Rule44",
        "formal": "(A56 ∨ A57)",
        "prover9_expression": "(quality_control_issue(drug_x) | contamination_risk(drug_x))",
        "natural": "Either drug X has a quality control issue, or drug X has a contamination risk."
      },
      {
        "id": "Rule45",
        "formal": "(A57 → (A55 ∨ ¬A19))",
        "prover9_expression": "(contamination_risk(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "Provided that drug X has a contamination risk, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
      },
      {
        "id": "Rule46",
        "formal": "(A58 → (A55 ∨ ¬A19))",
        "prover9_expression": "(batch_recall(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "In the event that a batch recall is issued for drug X, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
      },
      {
        "id": "Rule47",
        "formal": "(A60 ∨ A61)",
        "prover9_expression": "(production_halt(drug_x) | raw_material_shortage(drug_x))",
        "natural": "Either production of drug X is halted, or drug X has a raw material shortage."
      },
      {
        "id": "Rule48",
        "formal": "(A61 → (A17 ∨ A18))",
        "prover9_expression": "(raw_material_shortage(drug_x) -> (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
        "natural": "Should drug X have a raw material shortage, then either a safety profile for drug X is established or efficacy of drug X is demonstrated."
      },
      {
        "id": "Rule49",
        "formal": "(A62 → (A60 → A59))",
        "prover9_expression": "(manufacturing_audit(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
        "natural": "If a manufacturing audit is conducted for drug X, then if production of drug X is halted, drug X has a supply shortage."
      },
      {
        "id": "Rule50",
        "formal": "(A62 ∨ A63)",
        "prover9_expression": "(manufacturing_audit(drug_x) | process_validation(drug_x))",
        "natural": "A manufacturing audit is conducted for drug X, or process validation is performed for drug X."
      },
      {
        "id": "Rule51",
        "formal": "(A63 → (A60 → A59))",
        "prover9_expression": "(process_validation(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
        "natural": "Provided that process validation is performed for drug X, then if production of drug X is halted, drug X has a supply shortage."
      },
      {
        "id": "Rule52",
        "formal": "(A65 → (A64 ∨ ¬A19))",
        "prover9_expression": "(shelf_life_reduction(drug_x) -> (stability_issue(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "In case the shelf life of drug X is reduced, then either drug X has a stability issue or it is not the case that drug X is withdrawn from the market."
      },
      {
        "id": "Rule53",
        "formal": "(A66 → A65)",
        "prover9_expression": "(storage_requirements(drug_x) -> shelf_life_reduction(drug_x))",
        "natural": "If drug X has storage requirements, then the shelf life of drug X is reduced."
      },
      {
        "id": "Rule54",
        "formal": "(A67 → A66)",
        "prover9_expression": "(temperature_sensitive(drug_x) -> storage_requirements(drug_x))",
        "natural": "Whenever drug X is temperature sensitive, then drug X has storage requirements."
      },
      {
        "id": "Rule55",
        "formal": "(A8 → A7)",
        "prover9_expression": "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
        "natural": "Provided that drug X has severe side effects, then drug X has side effects."
      },
      {
        "id": "Rule56",
        "formal": "(A8 ∨ A9)",
        "prover9_expression": "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
        "natural": "Drug X has severe side effects, or drug X has mild side effects."
      },
      {
        "id": "Rule57",
        "formal": "(¬(A2 → ¬A1) → A4)",
        "prover9_expression": "(-(rejected(drug_x) -> -approved(drug_x)) -> requires_clinical_trial(drug_x))",
        "natural": "If it is not the case that if drug X is rejected, then it is not the case that drug X is approved, then drug X requires a clinical trial."
      },
      {
        "id": "Rule58",
        "formal": "(¬(A34 → (A30 ∨ A31)) → A35)",
        "prover9_expression": "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> profitability_decline(drug_x))",
        "natural": "Should it not be the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then profitability of drug X declines."
      },
      {
        "id": "Rule59",
        "formal": "(¬(A34 → (A30 ∨ A31)) → ¬A35)",
        "prover9_expression": "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> -profitability_decline(drug_x))",
        "natural": "If it is not the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then it is not the case that profitability of drug X declines."
      },
      {
        "id": "Rule60",
        "formal": "(¬(A4 → A5) → A6)",
        "prover9_expression": "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> clinical_trial_failed(drug_x))",
        "natural": "Provided that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then the clinical trial for drug X has failed."
      },
      {
        "id": "Rule61",
        "formal": "(¬(A4 → A5) → ¬A6)",
        "prover9_expression": "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> -clinical_trial_failed(drug_x))",
        "natural": "In the event that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then it is not the case that the clinical trial for drug X has failed."
      },
      {
        "id": "Rule62",
        "formal": "(¬(A41 → (A9 → A39)) → A42)",
        "prover9_expression": "(-(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x))) -> safety_concerns(drug_x))",
        "natural": "Assuming it is not the case that if drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring, then there are safety concerns for drug X."
      },
      {
        "id": "Rule63",
        "formal": "(¬(A44 → (¬(A9 → G) → A10)) → ¬A45)",
        "prover9_expression": "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> -data_integrity_issue(drug_x))",
        "natural": "Should it not be the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then it is not the case that drug X has a data integrity issue."
      },
      {
        "id": "Rule64",
        "formal": "(¬(A9 → G) → ¬A10)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -requires_warning_label(drug_x))",
        "natural": "If the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X requires a warning label."
      },
      {
        "id": "Rule65",
        "formal": "(¬(A9 → G) → ¬A49)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -restricted_distribution(drug_x))",
        "natural": "Assuming the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X has restricted distribution."
      },
      {
        "id": "Rule66",
        "formal": "(¬A25 → A26)",
        "prover9_expression": "(-patent_protected(drug_x) -> generic_available(drug_x))",
        "natural": "Should it not be the case that drug X is patent protected, then a generic version of drug X is available."
      },
      {
        "id": "Rule67",
        "formal": "(¬A51 → A52)",
        "prover9_expression": "(-controlled_substance(drug_x) -> prescription_required(drug_x))",
        "natural": "In the event that it is not the case that drug X is a controlled substance, then a prescription is required for drug X."
      },
      {
        "id": "Rule68",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-safe_for_use(drug_x) -> approved(drug_x))",
        "natural": "If it is not the case that drug X is safe for use, then drug X is approved."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A48",
        "prover9_expression": "compliance_certified(drug_x)",
        "natural": "Drug X is compliance certified."
      },
      {
        "id": "Fact2",
        "formal": "A67",
        "prover9_expression": "temperature_sensitive(drug_x)",
        "natural": "Drug X is temperature sensitive."
      },
      {
        "id": "Fact3",
        "formal": "¬A12",
        "prover9_expression": "-fast_track_approval(drug_x)",
        "natural": "It is not the case that drug X receives fast track approval."
      },
      {
        "id": "Fact4",
        "formal": "¬A20",
        "prover9_expression": "-voluntary_recall(drug_x)",
        "natural": "It is not the case that drug X is voluntarily recalled."
      },
      {
        "id": "Fact5",
        "formal": "¬A32",
        "prover9_expression": "-competitive_market_entry(drug_x)",
        "natural": "It is not the case that competitive market entry occurs for drug X."
      },
      {
        "id": "Fact6",
        "formal": "¬A42",
        "prover9_expression": "-safety_concerns(drug_x)",
        "natural": "It is not the case that there are safety concerns for drug X."
      },
      {
        "id": "Fact7",
        "formal": "¬A5",
        "prover9_expression": "-clinical_trial_completed(drug_x)",
        "natural": "It is not the case that the clinical trial for drug X is completed."
      },
      {
        "id": "Fact8",
        "formal": "¬A55",
        "prover9_expression": "-manufacturing_defect(drug_x)",
        "natural": "It is not the case that drug X has a manufacturing defect."
      },
      {
        "id": "Fact9",
        "formal": "¬A59",
        "prover9_expression": "-supply_shortage(drug_x)",
        "natural": "It is not the case that drug X has a supply shortage."
      },
      {
        "id": "Fact10",
        "formal": "¬A64",
        "prover9_expression": "-stability_issue(drug_x)",
        "natural": "It is not the case that drug X has a stability issue."
      },
      {
        "id": "Fact11",
        "formal": "¬A7",
        "prover9_expression": "-has_side_effects(drug_x)",
        "natural": "It is not the case that drug X has side effects."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "safe_for_use(drug_x)",
    "natural": "Drug X is safe for use."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A4 -> A5) -> A6)",
            "(-(A4 -> A5) -> -A6)"
          ],
          "conclusion": "(A4 -> A5)",
          "natural": "If drug X requires a clinical trial, then the clinical trial for drug X is completed."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A4 -> A5)",
            "-A5"
          ],
          "conclusion": "-A4",
          "natural": "It is not the case that drug X requires a clinical trial."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A2 -> -A1) -> A4)",
            "-A4"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "If drug X is rejected, then it is not the case that drug X is approved."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A12 | (-(A9 -> G) -> A11))",
            "-A12"
          ],
          "conclusion": "(-(A9 -> G) -> A11)",
          "natural": "Provided that the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 -> G) -> A11)",
            "(A11 -> A10)"
          ],
          "conclusion": "(-(A9 -> G) -> A10)",
          "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> G) -> A10)",
            "(-(A9 -> G) -> -A10)"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A8 -> A7)",
            "(A9 -> G)",
            "(A8 | A9)"
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | G)",
            "-A7"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A20 | -A19)",
            "-A20"
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 | A18))",
            "-A19"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A15 | A16))",
            "(A18 -> (A15 | A16))"
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A13)",
            "(A16 -> A14)",
            "(A15 | A16)"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> G)",
            "(A14 -> G)"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A21 -> A24)",
            "(A24 -> A23)"
          ],
          "conclusion": "(A21 -> A23)",
          "natural": "If drug X has a regulatory violation, then the license for drug X is suspended."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A21 -> A23)",
            "(A23 -> -A22)"
          ],
          "conclusion": "(A21 -> -A22)",
          "natural": "In case drug X has a regulatory violation, then it is not the case that a fine is imposed on drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(A21 -> A22)",
            "(A21 -> -A22)"
          ],
          "conclusion": "-A21",
          "natural": "It is not the case that drug X has a regulatory violation."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A21 | (A2 -> -A1))",
            "-A21"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "If drug X is rejected, then it is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A34 -> (A30 | A31)) -> A35)",
            "(-(A34 -> (A30 | A31)) -> -A35)"
          ],
          "conclusion": "(A34 -> (A30 | A31))",
          "natural": "Assuming drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A33 -> A32)",
            "(A34 -> (A30 | A31))",
            "(A33 | A34)"
          ],
          "conclusion": "(A32 | (A30 | A31))",
          "natural": "Competitive market entry occurs for drug X, or a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A32 | (A30 | A31))",
            "-A32"
          ],
          "conclusion": "(A30 | A31)",
          "natural": "Either a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A30 -> A28)",
            "(A31 -> A29)",
            "(A30 | A31)"
          ],
          "conclusion": "(A28 | A29)",
          "natural": "Either the patent for drug X has expired, or the patent for drug X is challenged."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A28 | A29)",
            "(A28 -> (-A25 -> A27))",
            "(A29 -> (-A25 -> A27))"
          ],
          "conclusion": "(-A25 -> A27)",
          "natural": "If it is not the case that drug X is patent protected, then drug X has exclusive marketing rights."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-A25 -> A27)",
            "(A27 -> -A26)"
          ],
          "conclusion": "(-A25 -> -A26)",
          "natural": "Provided that it is not the case that drug X is patent protected, then it is not the case that a generic version of drug X is available."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A25 -> A26)",
            "(-A25 -> -A26)"
          ],
          "conclusion": "A25",
          "natural": "Drug X is patent protected."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A25 -> -A1)",
            "A25"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A37 | A38)",
            "(A37 -> -A36)",
            "(A38 -> -A36)"
          ],
          "conclusion": "-A36",
          "natural": "It is not the case that drug X has orphan drug status."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A36 | -A4)",
            "-A36"
          ],
          "conclusion": "-A4",
          "natural": "It is not the case that drug X requires a clinical trial."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A2 -> -A1) -> A4)",
            "-A4"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "If drug X is rejected, then it is not the case that drug X is approved."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A41 -> (A9 -> A39)) -> A42)",
            "-A42"
          ],
          "conclusion": "(A41 -> (A9 -> A39))",
          "natural": "In the event that drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A40 | A41)",
            "(A40 -> (A9 -> A39))",
            "(A41 -> (A9 -> A39))"
          ],
          "conclusion": "(A9 -> A39)",
          "natural": "Assuming drug X has mild side effects, then drug X requires monitoring."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A9 -> A39)",
            "(A39 -> G)"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A8 -> A7)",
            "(A9 -> G)",
            "(A8 | A9)"
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | G)",
            "-A7"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A48 -> (A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45)))",
            "A48"
          ],
          "conclusion": "(A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
          "natural": "If an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A46 | A47)",
            "(A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
            "(A47 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))"
          ],
          "conclusion": "(-(A44 -> (-(A9 -> G) -> A10)) -> A45)",
          "natural": "If it is not the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A44 -> (-(A9 -> G) -> A10)) -> A45)",
            "(-(A44 -> (-(A9 -> G) -> A10)) -> -A45)"
          ],
          "conclusion": "(A44 -> (-(A9 -> G) -> A10))",
          "natural": "Provided that a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A43 | A44)",
            "(A43 -> (-(A9 -> G) -> A10))",
            "(A44 -> (-(A9 -> G) -> A10))"
          ],
          "conclusion": "(-(A9 -> G) -> A10)",
          "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> G) -> A10)",
            "(-(A9 -> G) -> -A10)"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            "(A8 -> A7)",
            "(A9 -> G)",
            "(A8 | A9)"
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | G)",
            "-A7"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A52 -> A54)",
            "(A54 -> A53)"
          ],
          "conclusion": "(A52 -> A53)",
          "natural": "Assuming a prescription is required for drug X, then physician authorization is needed for drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(A52 -> A53)",
            "(A52 -> -A53)"
          ],
          "conclusion": "-A52",
          "natural": "It is not the case that a prescription is required for drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-A51 -> A52)",
            "-A52"
          ],
          "conclusion": "A51",
          "natural": "Drug X is a controlled substance."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A51 -> (-(A9 -> G) -> A50))",
            "A51"
          ],
          "conclusion": "(-(A9 -> G) -> A50)",
          "natural": "Whenever the absence of mild side effects does not imply drug X is safe for use, then drug X requires special handling."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 -> G) -> A50)",
            "(A50 -> A49)"
          ],
          "conclusion": "(-(A9 -> G) -> A49)",
          "natural": "In case the absence of mild side effects does not imply drug X is safe for use, then drug X has restricted distribution."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> G) -> A49)",
            "(-(A9 -> G) -> -A49)"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 7,
          "rule_applied": "CD",
          "premises_used": [
            "(A8 -> A7)",
            "(A9 -> G)",
            "(A8 | A9)"
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | G)",
            "-A7"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A56 -> A58)",
            "(A58 -> (A55 | -A19))"
          ],
          "conclusion": "(A56 -> (A55 | -A19))",
          "natural": "Whenever drug X has a quality control issue, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A56 | A57)",
            "(A56 -> (A55 | -A19))",
            "(A57 -> (A55 | -A19))"
          ],
          "conclusion": "(A55 | -A19)",
          "natural": "Drug X has a manufacturing defect, or it is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A55 | -A19)",
            "-A55"
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 | A18))",
            "-A19"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A15 | A16))",
            "(A18 -> (A15 | A16))"
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A13)",
            "(A16 -> A14)",
            "(A15 | A16)"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> G)",
            "(A14 -> G)"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 11,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A62 | A63)",
            "(A62 -> (A60 -> A59))",
            "(A63 -> (A60 -> A59))"
          ],
          "conclusion": "(A60 -> A59)",
          "natural": "Assuming production of drug X is halted, then drug X has a supply shortage."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A60 -> A59)",
            "(A61 -> (A17 | A18))",
            "(A60 | A61)"
          ],
          "conclusion": "(A59 | (A17 | A18))",
          "natural": "Drug X has a supply shortage, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A59 | (A17 | A18))",
            "-A59"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A15 | A16))",
            "(A18 -> (A15 | A16))"
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A13)",
            "(A16 -> A14)",
            "(A15 | A16)"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> G)",
            "(A14 -> G)"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 12,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A67 -> A66)",
            "A67"
          ],
          "conclusion": "A66",
          "natural": "Drug X has storage requirements."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A66 -> A65)",
            "A66"
          ],
          "conclusion": "A65",
          "natural": "The shelf life of drug X is reduced."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A65 -> (A64 | -A19))",
            "A65"
          ],
          "conclusion": "(A64 | -A19)",
          "natural": "Drug X has a stability issue, or it is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A64 | -A19)",
            "-A64"
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 | A18))",
            "-A19"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A15 | A16))",
            "(A18 -> (A15 | A16))"
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 7,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A13)",
            "(A16 -> A14)",
            "(A15 | A16)"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 8,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> G)",
            "(A14 -> G)"
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Regulatory Compliance",
    "atomic_facts": {
      "A1": "approved(drug_x)",
      "A2": "rejected(drug_x)",
      "A3": "pending_review(drug_x)",
      "A4": "requires_clinical_trial(drug_x)",
      "A5": "clinical_trial_completed(drug_x)",
      "A6": "clinical_trial_failed(drug_x)",
      "A7": "has_side_effects(drug_x)",
      "A8": "severe_side_effects(drug_x)",
      "A9": "mild_side_effects(drug_x)",
      "A10": "requires_warning_label(drug_x)",
      "A11": "requires_black_box_warning(drug_x)",
      "A12": "fast_track_approval(drug_x)",
      "A13": "phase1_complete(drug_x)",
      "A14": "phase2_complete(drug_x)",
      "A15": "animal_testing_complete(drug_x)",
      "A16": "preliminary_human_trials_complete(drug_x)",
      "A17": "safety_profile_established(drug_x)",
      "A18": "efficacy_demonstrated(drug_x)",
      "A19": "market_withdrawal(drug_x)",
      "A20": "voluntary_recall(drug_x)",
      "A21": "regulatory_violation(drug_x)",
      "A22": "fine_imposed(drug_x)",
      "A23": "license_suspended(drug_x)",
      "A24": "criminal_charges(drug_x)",
      "A25": "patent_protected(drug_x)",
      "A26": "generic_available(drug_x)",
      "A27": "exclusive_marketing(drug_x)",
      "A28": "patent_expired(drug_x)",
      "A29": "patent_challenged(drug_x)",
      "A30": "generic_application_submitted(drug_x)",
      "A31": "biosimilar_application_submitted(drug_x)",
      "A32": "competitive_market_entry(drug_x)",
      "A33": "price_reduction(drug_x)",
      "A34": "market_share_loss(drug_x)",
      "A35": "profitability_decline(drug_x)",
      "A36": "orphan_drug_status(drug_x)",
      "A37": "rare_disease_indication(drug_x)",
      "A38": "unmet_medical_need(drug_x)",
      "A39": "requires_monitoring(drug_x)",
      "A40": "post_market_surveillance(drug_x)",
      "A41": "risk_management_program(drug_x)",
      "A42": "safety_concerns(drug_x)",
      "A43": "adverse_event_reporting(drug_x)",
      "A44": "patient_registry(drug_x)",
      "A45": "data_integrity_issue(drug_x)",
      "A46": "audit_scheduled(drug_x)",
      "A47": "inspection_required(drug_x)",
      "A48": "compliance_certified(drug_x)",
      "A49": "restricted_distribution(drug_x)",
      "A50": "special_handling(drug_x)",
      "A51": "controlled_substance(drug_x)",
      "A52": "prescription_required(drug_x)",
      "A53": "physician_authorization(drug_x)",
      "A54": "specialist_referral(drug_x)",
      "A55": "manufacturing_defect(drug_x)",
      "A56": "quality_control_issue(drug_x)",
      "A57": "contamination_risk(drug_x)",
      "A58": "batch_recall(drug_x)",
      "A59": "supply_shortage(drug_x)",
      "A60": "production_halt(drug_x)",
      "A61": "raw_material_shortage(drug_x)",
      "A62": "manufacturing_audit(drug_x)",
      "A63": "process_validation(drug_x)",
      "A64": "stability_issue(drug_x)",
      "A65": "shelf_life_reduction(drug_x)",
      "A66": "storage_requirements(drug_x)",
      "A67": "temperature_sensitive(drug_x)",
      "G": "safe_for_use(drug_x)"
    },
    "natural_facts": {
      "A1": "Drug X is approved.",
      "A2": "Drug X is rejected.",
      "A3": "Drug X is pending review.",
      "A4": "Drug X requires a clinical trial.",
      "A5": "The clinical trial for drug X is completed.",
      "A6": "The clinical trial for drug X has failed.",
      "A7": "Drug X has side effects.",
      "A8": "Drug X has severe side effects.",
      "A9": "Drug X has mild side effects.",
      "A10": "Drug X requires a warning label.",
      "A11": "Drug X requires a black box warning.",
      "A12": "Drug X receives fast track approval.",
      "A13": "Phase 1 for drug X is complete.",
      "A14": "Phase 2 for drug X is complete.",
      "A15": "Animal testing for drug X is complete.",
      "A16": "Preliminary human trials for drug X are complete.",
      "A17": "A safety profile for drug X is established.",
      "A18": "Efficacy of drug X is demonstrated.",
      "A19": "Drug X is withdrawn from the market.",
      "A20": "Drug X is voluntarily recalled.",
      "A21": "Drug X has a regulatory violation.",
      "A22": "A fine is imposed on drug X.",
      "A23": "The license for drug X is suspended.",
      "A24": "Criminal charges are filed for drug X.",
      "A25": "Drug X is patent protected.",
      "A26": "A generic version of drug X is available.",
      "A27": "Drug X has exclusive marketing rights.",
      "A28": "The patent for drug X has expired.",
      "A29": "The patent for drug X is challenged.",
      "A30": "A generic application for drug X is submitted.",
      "A31": "A biosimilar application for drug X is submitted.",
      "A32": "Competitive market entry occurs for drug X.",
      "A33": "The price of drug X is reduced.",
      "A34": "Drug X experiences market share loss.",
      "A35": "Profitability of drug X declines.",
      "A36": "Drug X has orphan drug status.",
      "A37": "Drug X has a rare disease indication.",
      "A38": "Drug X addresses an unmet medical need.",
      "A39": "Drug X requires monitoring.",
      "A40": "Drug X is under post-market surveillance.",
      "A41": "Drug X has a risk management program.",
      "A42": "There are safety concerns for drug X.",
      "A43": "Adverse event reporting is conducted for drug X.",
      "A44": "A patient registry exists for drug X.",
      "A45": "Drug X has a data integrity issue.",
      "A46": "An audit is scheduled for drug X.",
      "A47": "An inspection is required for drug X.",
      "A48": "Drug X is compliance certified.",
      "A49": "Drug X has restricted distribution.",
      "A50": "Drug X requires special handling.",
      "A51": "Drug X is a controlled substance.",
      "A52": "A prescription is required for drug X.",
      "A53": "Physician authorization is needed for drug X.",
      "A54": "A specialist referral is required for drug X.",
      "A55": "Drug X has a manufacturing defect.",
      "A56": "Drug X has a quality control issue.",
      "A57": "Drug X has a contamination risk.",
      "A58": "A batch recall is issued for drug X.",
      "A59": "Drug X has a supply shortage.",
      "A60": "Production of drug X is halted.",
      "A61": "Drug X has a raw material shortage.",
      "A62": "A manufacturing audit is conducted for drug X.",
      "A63": "Process validation is performed for drug X.",
      "A64": "Drug X has a stability issue.",
      "A65": "The shelf life of drug X is reduced.",
      "A66": "Drug X has storage requirements.",
      "A67": "Drug X is temperature sensitive.",
      "G": "Drug X is safe for use."
    },
    "prover9_expressions": [
      "(requires_black_box_warning(drug_x) -> requires_warning_label(drug_x))",
      "(fast_track_approval(drug_x) | (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x)))",
      "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
      "(phase1_complete(drug_x) | phase2_complete(drug_x))",
      "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
      "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
      "(animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x))",
      "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
      "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
      "(safety_profile_established(drug_x) | efficacy_demonstrated(drug_x))",
      "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
      "(market_withdrawal(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
      "(rejected(drug_x) -> -approved(drug_x))",
      "(rejected(drug_x) | pending_review(drug_x))",
      "(voluntary_recall(drug_x) | -market_withdrawal(drug_x))",
      "(regulatory_violation(drug_x) -> fine_imposed(drug_x))",
      "(regulatory_violation(drug_x) -> license_suspended(drug_x))",
      "(regulatory_violation(drug_x) -> criminal_charges(drug_x))",
      "(regulatory_violation(drug_x) -> -fine_imposed(drug_x))",
      "(regulatory_violation(drug_x) | (rejected(drug_x) -> -approved(drug_x)))",
      "(license_suspended(drug_x) -> -fine_imposed(drug_x))",
      "(criminal_charges(drug_x) -> license_suspended(drug_x))",
      "(patent_protected(drug_x) -> -approved(drug_x))",
      "(exclusive_marketing(drug_x) -> -generic_available(drug_x))",
      "(patent_expired(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
      "(patent_expired(drug_x) | patent_challenged(drug_x))",
      "(patent_challenged(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
      "(pending_review(drug_x) -> -approved(drug_x))",
      "(generic_application_submitted(drug_x) -> patent_expired(drug_x))",
      "(generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))",
      "(biosimilar_application_submitted(drug_x) -> patent_challenged(drug_x))",
      "(competitive_market_entry(drug_x) | (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x)))",
      "(price_reduction(drug_x) -> competitive_market_entry(drug_x))",
      "(price_reduction(drug_x) | market_share_loss(drug_x))",
      "(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x)))",
      "(orphan_drug_status(drug_x) | -requires_clinical_trial(drug_x))",
      "(rare_disease_indication(drug_x) -> -orphan_drug_status(drug_x))",
      "(rare_disease_indication(drug_x) | unmet_medical_need(drug_x))",
      "(unmet_medical_need(drug_x) -> -orphan_drug_status(drug_x))",
      "(requires_monitoring(drug_x) -> safe_for_use(drug_x))",
      "(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x))",
      "(post_market_surveillance(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
      "(post_market_surveillance(drug_x) | risk_management_program(drug_x))",
      "(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
      "(adverse_event_reporting(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
      "(adverse_event_reporting(drug_x) | patient_registry(drug_x))",
      "(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
      "(audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
      "(audit_scheduled(drug_x) | inspection_required(drug_x))",
      "(inspection_required(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
      "(compliance_certified(drug_x) -> (audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))))",
      "(special_handling(drug_x) -> restricted_distribution(drug_x))",
      "(controlled_substance(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x)))",
      "(prescription_required(drug_x) -> physician_authorization(drug_x))",
      "(prescription_required(drug_x) -> specialist_referral(drug_x))",
      "(prescription_required(drug_x) -> -physician_authorization(drug_x))",
      "(specialist_referral(drug_x) -> physician_authorization(drug_x))",
      "(manufacturing_defect(drug_x) | -market_withdrawal(drug_x))",
      "(quality_control_issue(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
      "(quality_control_issue(drug_x) -> batch_recall(drug_x))",
      "(quality_control_issue(drug_x) | contamination_risk(drug_x))",
      "(contamination_risk(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
      "(batch_recall(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
      "(supply_shortage(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
      "(production_halt(drug_x) -> supply_shortage(drug_x))",
      "(production_halt(drug_x) | raw_material_shortage(drug_x))",
      "(raw_material_shortage(drug_x) -> (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
      "(manufacturing_audit(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
      "(manufacturing_audit(drug_x) | process_validation(drug_x))",
      "(process_validation(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
      "(stability_issue(drug_x) | -market_withdrawal(drug_x))",
      "(shelf_life_reduction(drug_x) -> (stability_issue(drug_x) | -market_withdrawal(drug_x)))",
      "(storage_requirements(drug_x) -> shelf_life_reduction(drug_x))",
      "(temperature_sensitive(drug_x) -> storage_requirements(drug_x))",
      "(has_side_effects(drug_x) | safe_for_use(drug_x))",
      "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
      "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
      "(mild_side_effects(drug_x) -> requires_monitoring(drug_x))",
      "(mild_side_effects(drug_x) -> safe_for_use(drug_x))",
      "(-(rejected(drug_x) -> -approved(drug_x)) -> requires_clinical_trial(drug_x))",
      "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> profitability_decline(drug_x))",
      "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> -profitability_decline(drug_x))",
      "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> clinical_trial_failed(drug_x))",
      "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> -clinical_trial_failed(drug_x))",
      "(-(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x))) -> safety_concerns(drug_x))",
      "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))",
      "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> -data_integrity_issue(drug_x))",
      "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))",
      "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x))",
      "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> restricted_distribution(drug_x))",
      "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x))",
      "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -requires_warning_label(drug_x))",
      "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -restricted_distribution(drug_x))",
      "(-patent_protected(drug_x) -> generic_available(drug_x))",
      "(-patent_protected(drug_x) -> exclusive_marketing(drug_x))",
      "(-patent_protected(drug_x) -> -generic_available(drug_x))",
      "(-controlled_substance(drug_x) -> prescription_required(drug_x))",
      "(-safe_for_use(drug_x) -> approved(drug_x))",
      "patent_protected(drug_x)",
      "compliance_certified(drug_x)",
      "controlled_substance(drug_x)",
      "shelf_life_reduction(drug_x)",
      "storage_requirements(drug_x)",
      "temperature_sensitive(drug_x)",
      "safe_for_use(drug_x)",
      "-approved(drug_x)",
      "-fast_track_approval(drug_x)",
      "-market_withdrawal(drug_x)",
      "-voluntary_recall(drug_x)",
      "-regulatory_violation(drug_x)",
      "-competitive_market_entry(drug_x)",
      "-orphan_drug_status(drug_x)",
      "-requires_clinical_trial(drug_x)",
      "-safety_concerns(drug_x)",
      "-clinical_trial_completed(drug_x)",
      "-prescription_required(drug_x)",
      "-manufacturing_defect(drug_x)",
      "-supply_shortage(drug_x)",
      "-stability_issue(drug_x)",
      "-has_side_effects(drug_x)"
    ],
    "natural_expressions": [
      "If drug X requires a black box warning, then drug X requires a warning label.",
      "Either drug X receives fast track approval, or if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning.",
      "Provided that phase 1 for drug X is complete, drug X is safe for use.",
      "Either phase 1 for drug X is complete, or phase 2 for drug X is complete.",
      "Whenever phase 2 for drug X is complete, drug X is safe for use.",
      "If animal testing for drug X is complete, then phase 1 for drug X is complete.",
      "Animal testing for drug X is complete, or preliminary human trials for drug X are complete.",
      "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete.",
      "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete.",
      "A safety profile for drug X is established, or efficacy of drug X is demonstrated.",
      "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete.",
      "Drug X is withdrawn from the market, or a safety profile for drug X is established, or efficacy of drug X is demonstrated.",
      "If drug X is rejected, then it is not the case that drug X is approved.",
      "Either drug X is rejected, or drug X is pending review.",
      "Drug X is voluntarily recalled, or it is not the case that drug X is withdrawn from the market.",
      "Provided that drug X has a regulatory violation, a fine is imposed on drug X.",
      "If drug X has a regulatory violation, then the license for drug X is suspended.",
      "Whenever drug X has a regulatory violation, criminal charges are filed for drug X.",
      "In case drug X has a regulatory violation, then it is not the case that a fine is imposed on drug X.",
      "Drug X has a regulatory violation, or if drug X is rejected, then it is not the case that drug X is approved.",
      "Should the license for drug X be suspended, then it is not the case that a fine is imposed on drug X.",
      "If criminal charges are filed for drug X, then the license for drug X is suspended.",
      "Assuming drug X is patent protected, then it is not the case that drug X is approved.",
      "Provided that drug X has exclusive marketing rights, then it is not the case that a generic version of drug X is available.",
      "If the patent for drug X has expired, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights.",
      "Either the patent for drug X has expired, or the patent for drug X is challenged.",
      "In the event that the patent for drug X is challenged, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights.",
      "Should drug X be pending review, then it is not the case that drug X is approved.",
      "If a generic application for drug X is submitted, then the patent for drug X has expired.",
      "Either a generic application for drug X is submitted, or a biosimilar application for drug X is submitted.",
      "Provided that a biosimilar application for drug X is submitted, then the patent for drug X is challenged.",
      "Competitive market entry occurs for drug X, or a generic application for drug X is submitted, or a biosimilar application for drug X is submitted.",
      "Whenever the price of drug X is reduced, competitive market entry occurs for drug X.",
      "The price of drug X is reduced, or drug X experiences market share loss.",
      "Assuming drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted.",
      "Drug X has orphan drug status, or it is not the case that drug X requires a clinical trial.",
      "If drug X has a rare disease indication, then it is not the case that drug X has orphan drug status.",
      "Either drug X has a rare disease indication, or drug X addresses an unmet medical need.",
      "In case drug X addresses an unmet medical need, then it is not the case that drug X has orphan drug status.",
      "Provided that drug X requires monitoring, then drug X is safe for use.",
      "If drug X requires a clinical trial, then the clinical trial for drug X is completed.",
      "Should drug X be under post-market surveillance, then if drug X has mild side effects, drug X requires monitoring.",
      "Drug X is under post-market surveillance, or drug X has a risk management program.",
      "In the event that drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring.",
      "Assuming adverse event reporting is conducted for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label.",
      "Adverse event reporting is conducted for drug X, or a patient registry exists for drug X.",
      "Provided that a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label.",
      "If an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue.",
      "Either an audit is scheduled for drug X, or an inspection is required for drug X.",
      "Whenever an inspection is required for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue.",
      "Should drug X be compliance certified, then if an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue.",
      "If drug X requires special handling, then drug X has restricted distribution.",
      "Provided that drug X is a controlled substance, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires special handling.",
      "Assuming a prescription is required for drug X, then physician authorization is needed for drug X.",
      "If a prescription is required for drug X, then a specialist referral is required for drug X.",
      "In case a prescription is required for drug X, then it is not the case that physician authorization is needed for drug X.",
      "Should a specialist referral be required for drug X, then physician authorization is needed for drug X.",
      "Drug X has a manufacturing defect, or it is not the case that drug X is withdrawn from the market.",
      "Whenever drug X has a quality control issue, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market.",
      "If drug X has a quality control issue, then a batch recall is issued for drug X.",
      "Either drug X has a quality control issue, or drug X has a contamination risk.",
      "Provided that drug X has a contamination risk, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market.",
      "In the event that a batch recall is issued for drug X, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market.",
      "Drug X has a supply shortage, or a safety profile for drug X is established, or efficacy of drug X is demonstrated.",
      "Assuming production of drug X is halted, then drug X has a supply shortage.",
      "Either production of drug X is halted, or drug X has a raw material shortage.",
      "Should drug X have a raw material shortage, then either a safety profile for drug X is established or efficacy of drug X is demonstrated.",
      "If a manufacturing audit is conducted for drug X, then if production of drug X is halted, drug X has a supply shortage.",
      "A manufacturing audit is conducted for drug X, or process validation is performed for drug X.",
      "Provided that process validation is performed for drug X, then if production of drug X is halted, drug X has a supply shortage.",
      "Drug X has a stability issue, or it is not the case that drug X is withdrawn from the market.",
      "In case the shelf life of drug X is reduced, then either drug X has a stability issue or it is not the case that drug X is withdrawn from the market.",
      "If drug X has storage requirements, then the shelf life of drug X is reduced.",
      "Whenever drug X is temperature sensitive, then drug X has storage requirements.",
      "Either drug X has side effects, or drug X is safe for use.",
      "Provided that drug X has severe side effects, then drug X has side effects.",
      "Drug X has severe side effects, or drug X has mild side effects.",
      "Assuming drug X has mild side effects, then drug X requires monitoring.",
      "If drug X has mild side effects, then drug X is safe for use.",
      "If it is not the case that if drug X is rejected, then it is not the case that drug X is approved, then drug X requires a clinical trial.",
      "Should it not be the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then profitability of drug X declines.",
      "If it is not the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then it is not the case that profitability of drug X declines.",
      "Provided that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then the clinical trial for drug X has failed.",
      "In the event that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then it is not the case that the clinical trial for drug X has failed.",
      "Assuming it is not the case that if drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring, then there are safety concerns for drug X.",
      "If it is not the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue.",
      "Should it not be the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then it is not the case that drug X has a data integrity issue.",
      "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label.",
      "Provided that the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning.",
      "In case the absence of mild side effects does not imply drug X is safe for use, then drug X has restricted distribution.",
      "Whenever the absence of mild side effects does not imply drug X is safe for use, then drug X requires special handling.",
      "If the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X requires a warning label.",
      "Assuming the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X has restricted distribution.",
      "Should it not be the case that drug X is patent protected, then a generic version of drug X is available.",
      "If it is not the case that drug X is patent protected, then drug X has exclusive marketing rights.",
      "Provided that it is not the case that drug X is patent protected, then it is not the case that a generic version of drug X is available.",
      "In the event that it is not the case that drug X is a controlled substance, then a prescription is required for drug X.",
      "If it is not the case that drug X is safe for use, then drug X is approved.",
      "Drug X is patent protected.",
      "Drug X is compliance certified.",
      "Drug X is a controlled substance.",
      "The shelf life of drug X is reduced.",
      "Drug X has storage requirements.",
      "Drug X is temperature sensitive.",
      "Drug X is safe for use.",
      "It is not the case that drug X is approved.",
      "It is not the case that drug X receives fast track approval.",
      "It is not the case that drug X is withdrawn from the market.",
      "It is not the case that drug X is voluntarily recalled.",
      "It is not the case that drug X has a regulatory violation.",
      "It is not the case that competitive market entry occurs for drug X.",
      "It is not the case that drug X has orphan drug status.",
      "It is not the case that drug X requires a clinical trial.",
      "It is not the case that there are safety concerns for drug X.",
      "It is not the case that the clinical trial for drug X is completed.",
      "It is not the case that a prescription is required for drug X.",
      "It is not the case that drug X has a manufacturing defect.",
      "It is not the case that drug X has a supply shortage.",
      "It is not the case that drug X has a stability issue.",
      "It is not the case that drug X has side effects."
    ],
    "node_mappings": {
      "(A11 → A10)": {
        "formal": "(A11 → A10)",
        "prover9": "(A11 -> A10)",
        "prover9_expression": "(requires_black_box_warning(drug_x) -> requires_warning_label(drug_x))",
        "natural": "If drug X requires a black box warning, then drug X requires a warning label."
      },
      "(A12 ∨ (¬(A9 → G) → A11))": {
        "formal": "(A12 ∨ (¬(A9 → G) → A11))",
        "prover9": "(A12 | (-(A9 -> G) -> A11))",
        "prover9_expression": "(fast_track_approval(drug_x) | (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x)))",
        "natural": "Either drug X receives fast track approval, or if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
      },
      "(A13 → G)": {
        "formal": "(A13 → G)",
        "prover9": "(A13 -> G)",
        "prover9_expression": "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
        "natural": "Provided that phase 1 for drug X is complete, drug X is safe for use."
      },
      "(A13 ∨ A14)": {
        "formal": "(A13 ∨ A14)",
        "prover9": "(A13 | A14)",
        "prover9_expression": "(phase1_complete(drug_x) | phase2_complete(drug_x))",
        "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
      },
      "(A14 → G)": {
        "formal": "(A14 → G)",
        "prover9": "(A14 -> G)",
        "prover9_expression": "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
        "natural": "Whenever phase 2 for drug X is complete, drug X is safe for use."
      },
      "(A15 → A13)": {
        "formal": "(A15 → A13)",
        "prover9": "(A15 -> A13)",
        "prover9_expression": "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
        "natural": "If animal testing for drug X is complete, then phase 1 for drug X is complete."
      },
      "(A15 ∨ A16)": {
        "formal": "(A15 ∨ A16)",
        "prover9": "(A15 | A16)",
        "prover9_expression": "(animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x))",
        "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
      },
      "(A16 → A14)": {
        "formal": "(A16 → A14)",
        "prover9": "(A16 -> A14)",
        "prover9_expression": "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
        "natural": "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete."
      },
      "(A17 → (A15 ∨ A16))": {
        "formal": "(A17 → (A15 ∨ A16))",
        "prover9": "(A17 -> (A15 | A16))",
        "prover9_expression": "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
        "natural": "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
      },
      "(A17 ∨ A18)": {
        "formal": "(A17 ∨ A18)",
        "prover9": "(A17 | A18)",
        "prover9_expression": "(safety_profile_established(drug_x) | efficacy_demonstrated(drug_x))",
        "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
      },
      "(A18 → (A15 ∨ A16))": {
        "formal": "(A18 → (A15 ∨ A16))",
        "prover9": "(A18 -> (A15 | A16))",
        "prover9_expression": "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
        "natural": "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
      },
      "(A19 ∨ (A17 ∨ A18))": {
        "formal": "(A19 ∨ (A17 ∨ A18))",
        "prover9": "(A19 | (A17 | A18))",
        "prover9_expression": "(market_withdrawal(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
        "natural": "Drug X is withdrawn from the market, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
      },
      "(A2 → ¬A1)": {
        "formal": "(A2 → ¬A1)",
        "prover9": "(A2 -> -A1)",
        "prover9_expression": "(rejected(drug_x) -> -approved(drug_x))",
        "natural": "If drug X is rejected, then it is not the case that drug X is approved."
      },
      "(A2 ∨ A3)": {
        "formal": "(A2 ∨ A3)",
        "prover9": "(A2 | A3)",
        "prover9_expression": "(rejected(drug_x) | pending_review(drug_x))",
        "natural": "Either drug X is rejected, or drug X is pending review."
      },
      "(A20 ∨ ¬A19)": {
        "formal": "(A20 ∨ ¬A19)",
        "prover9": "(A20 | -A19)",
        "prover9_expression": "(voluntary_recall(drug_x) | -market_withdrawal(drug_x))",
        "natural": "Drug X is voluntarily recalled, or it is not the case that drug X is withdrawn from the market."
      },
      "(A21 → A22)": {
        "formal": "(A21 → A22)",
        "prover9": "(A21 -> A22)",
        "prover9_expression": "(regulatory_violation(drug_x) -> fine_imposed(drug_x))",
        "natural": "Provided that drug X has a regulatory violation, a fine is imposed on drug X."
      },
      "(A21 → A23)": {
        "formal": "(A21 → A23)",
        "prover9": "(A21 -> A23)",
        "prover9_expression": "(regulatory_violation(drug_x) -> license_suspended(drug_x))",
        "natural": "If drug X has a regulatory violation, then the license for drug X is suspended."
      },
      "(A21 → A24)": {
        "formal": "(A21 → A24)",
        "prover9": "(A21 -> A24)",
        "prover9_expression": "(regulatory_violation(drug_x) -> criminal_charges(drug_x))",
        "natural": "Whenever drug X has a regulatory violation, criminal charges are filed for drug X."
      },
      "(A21 → ¬A22)": {
        "formal": "(A21 → ¬A22)",
        "prover9": "(A21 -> -A22)",
        "prover9_expression": "(regulatory_violation(drug_x) -> -fine_imposed(drug_x))",
        "natural": "In case drug X has a regulatory violation, then it is not the case that a fine is imposed on drug X."
      },
      "(A21 ∨ (A2 → ¬A1))": {
        "formal": "(A21 ∨ (A2 → ¬A1))",
        "prover9": "(A21 | (A2 -> -A1))",
        "prover9_expression": "(regulatory_violation(drug_x) | (rejected(drug_x) -> -approved(drug_x)))",
        "natural": "Drug X has a regulatory violation, or if drug X is rejected, then it is not the case that drug X is approved."
      },
      "(A23 → ¬A22)": {
        "formal": "(A23 → ¬A22)",
        "prover9": "(A23 -> -A22)",
        "prover9_expression": "(license_suspended(drug_x) -> -fine_imposed(drug_x))",
        "natural": "Should the license for drug X be suspended, then it is not the case that a fine is imposed on drug X."
      },
      "(A24 → A23)": {
        "formal": "(A24 → A23)",
        "prover9": "(A24 -> A23)",
        "prover9_expression": "(criminal_charges(drug_x) -> license_suspended(drug_x))",
        "natural": "If criminal charges are filed for drug X, then the license for drug X is suspended."
      },
      "(A25 → ¬A1)": {
        "formal": "(A25 → ¬A1)",
        "prover9": "(A25 -> -A1)",
        "prover9_expression": "(patent_protected(drug_x) -> -approved(drug_x))",
        "natural": "Assuming drug X is patent protected, then it is not the case that drug X is approved."
      },
      "(A27 → ¬A26)": {
        "formal": "(A27 → ¬A26)",
        "prover9": "(A27 -> -A26)",
        "prover9_expression": "(exclusive_marketing(drug_x) -> -generic_available(drug_x))",
        "natural": "Provided that drug X has exclusive marketing rights, then it is not the case that a generic version of drug X is available."
      },
      "(A28 → (¬A25 → A27))": {
        "formal": "(A28 → (¬A25 → A27))",
        "prover9": "(A28 -> (-A25 -> A27))",
        "prover9_expression": "(patent_expired(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
        "natural": "If the patent for drug X has expired, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights."
      },
      "(A28 ∨ A29)": {
        "formal": "(A28 ∨ A29)",
        "prover9": "(A28 | A29)",
        "prover9_expression": "(patent_expired(drug_x) | patent_challenged(drug_x))",
        "natural": "Either the patent for drug X has expired, or the patent for drug X is challenged."
      },
      "(A29 → (¬A25 → A27))": {
        "formal": "(A29 → (¬A25 → A27))",
        "prover9": "(A29 -> (-A25 -> A27))",
        "prover9_expression": "(patent_challenged(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
        "natural": "In the event that the patent for drug X is challenged, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights."
      },
      "(A3 → ¬A1)": {
        "formal": "(A3 → ¬A1)",
        "prover9": "(A3 -> -A1)",
        "prover9_expression": "(pending_review(drug_x) -> -approved(drug_x))",
        "natural": "Should drug X be pending review, then it is not the case that drug X is approved."
      },
      "(A30 → A28)": {
        "formal": "(A30 → A28)",
        "prover9": "(A30 -> A28)",
        "prover9_expression": "(generic_application_submitted(drug_x) -> patent_expired(drug_x))",
        "natural": "If a generic application for drug X is submitted, then the patent for drug X has expired."
      },
      "(A30 ∨ A31)": {
        "formal": "(A30 ∨ A31)",
        "prover9": "(A30 | A31)",
        "prover9_expression": "(generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))",
        "natural": "Either a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
      },
      "(A31 → A29)": {
        "formal": "(A31 → A29)",
        "prover9": "(A31 -> A29)",
        "prover9_expression": "(biosimilar_application_submitted(drug_x) -> patent_challenged(drug_x))",
        "natural": "Provided that a biosimilar application for drug X is submitted, then the patent for drug X is challenged."
      },
      "(A32 ∨ (A30 ∨ A31))": {
        "formal": "(A32 ∨ (A30 ∨ A31))",
        "prover9": "(A32 | (A30 | A31))",
        "prover9_expression": "(competitive_market_entry(drug_x) | (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x)))",
        "natural": "Competitive market entry occurs for drug X, or a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
      },
      "(A33 → A32)": {
        "formal": "(A33 → A32)",
        "prover9": "(A33 -> A32)",
        "prover9_expression": "(price_reduction(drug_x) -> competitive_market_entry(drug_x))",
        "natural": "Whenever the price of drug X is reduced, competitive market entry occurs for drug X."
      },
      "(A33 ∨ A34)": {
        "formal": "(A33 ∨ A34)",
        "prover9": "(A33 | A34)",
        "prover9_expression": "(price_reduction(drug_x) | market_share_loss(drug_x))",
        "natural": "The price of drug X is reduced, or drug X experiences market share loss."
      },
      "(A34 → (A30 ∨ A31))": {
        "formal": "(A34 → (A30 ∨ A31))",
        "prover9": "(A34 -> (A30 | A31))",
        "prover9_expression": "(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x)))",
        "natural": "Assuming drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted."
      },
      "(A36 ∨ ¬A4)": {
        "formal": "(A36 ∨ ¬A4)",
        "prover9": "(A36 | -A4)",
        "prover9_expression": "(orphan_drug_status(drug_x) | -requires_clinical_trial(drug_x))",
        "natural": "Drug X has orphan drug status, or it is not the case that drug X requires a clinical trial."
      },
      "(A37 → ¬A36)": {
        "formal": "(A37 → ¬A36)",
        "prover9": "(A37 -> -A36)",
        "prover9_expression": "(rare_disease_indication(drug_x) -> -orphan_drug_status(drug_x))",
        "natural": "If drug X has a rare disease indication, then it is not the case that drug X has orphan drug status."
      },
      "(A37 ∨ A38)": {
        "formal": "(A37 ∨ A38)",
        "prover9": "(A37 | A38)",
        "prover9_expression": "(rare_disease_indication(drug_x) | unmet_medical_need(drug_x))",
        "natural": "Either drug X has a rare disease indication, or drug X addresses an unmet medical need."
      },
      "(A38 → ¬A36)": {
        "formal": "(A38 → ¬A36)",
        "prover9": "(A38 -> -A36)",
        "prover9_expression": "(unmet_medical_need(drug_x) -> -orphan_drug_status(drug_x))",
        "natural": "In case drug X addresses an unmet medical need, then it is not the case that drug X has orphan drug status."
      },
      "(A39 → G)": {
        "formal": "(A39 → G)",
        "prover9": "(A39 -> G)",
        "prover9_expression": "(requires_monitoring(drug_x) -> safe_for_use(drug_x))",
        "natural": "Provided that drug X requires monitoring, then drug X is safe for use."
      },
      "(A4 → A5)": {
        "formal": "(A4 → A5)",
        "prover9": "(A4 -> A5)",
        "prover9_expression": "(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x))",
        "natural": "If drug X requires a clinical trial, then the clinical trial for drug X is completed."
      },
      "(A40 → (A9 → A39))": {
        "formal": "(A40 → (A9 → A39))",
        "prover9": "(A40 -> (A9 -> A39))",
        "prover9_expression": "(post_market_surveillance(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
        "natural": "Should drug X be under post-market surveillance, then if drug X has mild side effects, drug X requires monitoring."
      },
      "(A40 ∨ A41)": {
        "formal": "(A40 ∨ A41)",
        "prover9": "(A40 | A41)",
        "prover9_expression": "(post_market_surveillance(drug_x) | risk_management_program(drug_x))",
        "natural": "Drug X is under post-market surveillance, or drug X has a risk management program."
      },
      "(A41 → (A9 → A39))": {
        "formal": "(A41 → (A9 → A39))",
        "prover9": "(A41 -> (A9 -> A39))",
        "prover9_expression": "(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
        "natural": "In the event that drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring."
      },
      "(A43 → (¬(A9 → G) → A10))": {
        "formal": "(A43 → (¬(A9 → G) → A10))",
        "prover9": "(A43 -> (-(A9 -> G) -> A10))",
        "prover9_expression": "(adverse_event_reporting(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
        "natural": "Assuming adverse event reporting is conducted for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
      },
      "(A43 ∨ A44)": {
        "formal": "(A43 ∨ A44)",
        "prover9": "(A43 | A44)",
        "prover9_expression": "(adverse_event_reporting(drug_x) | patient_registry(drug_x))",
        "natural": "Adverse event reporting is conducted for drug X, or a patient registry exists for drug X."
      },
      "(A44 → (¬(A9 → G) → A10))": {
        "formal": "(A44 → (¬(A9 → G) → A10))",
        "prover9": "(A44 -> (-(A9 -> G) -> A10))",
        "prover9_expression": "(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
        "natural": "Provided that a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
      },
      "(A46 → (¬(A44 → (¬(A9 → G) → A10)) → A45))": {
        "formal": "(A46 → (¬(A44 → (¬(A9 → G) → A10)) → A45))",
        "prover9": "(A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
        "prover9_expression": "(audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
        "natural": "If an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
      },
      "(A46 ∨ A47)": {
        "formal": "(A46 ∨ A47)",
        "prover9": "(A46 | A47)",
        "prover9_expression": "(audit_scheduled(drug_x) | inspection_required(drug_x))",
        "natural": "Either an audit is scheduled for drug X, or an inspection is required for drug X."
      },
      "(A47 → (¬(A44 → (¬(A9 → G) → A10)) → A45))": {
        "formal": "(A47 → (¬(A44 → (¬(A9 → G) → A10)) → A45))",
        "prover9": "(A47 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
        "prover9_expression": "(inspection_required(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
        "natural": "Whenever an inspection is required for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
      },
      "(A48 → (A46 → (¬(A44 → (¬(A9 → G) → A10)) → A45)))": {
        "formal": "(A48 → (A46 → (¬(A44 → (¬(A9 → G) → A10)) → A45)))",
        "prover9": "(A48 -> (A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45)))",
        "prover9_expression": "(compliance_certified(drug_x) -> (audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))))",
        "natural": "Should drug X be compliance certified, then if an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
      },
      "(A50 → A49)": {
        "formal": "(A50 → A49)",
        "prover9": "(A50 -> A49)",
        "prover9_expression": "(special_handling(drug_x) -> restricted_distribution(drug_x))",
        "natural": "If drug X requires special handling, then drug X has restricted distribution."
      },
      "(A51 → (¬(A9 → G) → A50))": {
        "formal": "(A51 → (¬(A9 → G) → A50))",
        "prover9": "(A51 -> (-(A9 -> G) -> A50))",
        "prover9_expression": "(controlled_substance(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x)))",
        "natural": "Provided that drug X is a controlled substance, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires special handling."
      },
      "(A52 → A53)": {
        "formal": "(A52 → A53)",
        "prover9": "(A52 -> A53)",
        "prover9_expression": "(prescription_required(drug_x) -> physician_authorization(drug_x))",
        "natural": "Assuming a prescription is required for drug X, then physician authorization is needed for drug X."
      },
      "(A52 → A54)": {
        "formal": "(A52 → A54)",
        "prover9": "(A52 -> A54)",
        "prover9_expression": "(prescription_required(drug_x) -> specialist_referral(drug_x))",
        "natural": "If a prescription is required for drug X, then a specialist referral is required for drug X."
      },
      "(A52 → ¬A53)": {
        "formal": "(A52 → ¬A53)",
        "prover9": "(A52 -> -A53)",
        "prover9_expression": "(prescription_required(drug_x) -> -physician_authorization(drug_x))",
        "natural": "In case a prescription is required for drug X, then it is not the case that physician authorization is needed for drug X."
      },
      "(A54 → A53)": {
        "formal": "(A54 → A53)",
        "prover9": "(A54 -> A53)",
        "prover9_expression": "(specialist_referral(drug_x) -> physician_authorization(drug_x))",
        "natural": "Should a specialist referral be required for drug X, then physician authorization is needed for drug X."
      },
      "(A55 ∨ ¬A19)": {
        "formal": "(A55 ∨ ¬A19)",
        "prover9": "(A55 | -A19)",
        "prover9_expression": "(manufacturing_defect(drug_x) | -market_withdrawal(drug_x))",
        "natural": "Drug X has a manufacturing defect, or it is not the case that drug X is withdrawn from the market."
      },
      "(A56 → (A55 ∨ ¬A19))": {
        "formal": "(A56 → (A55 ∨ ¬A19))",
        "prover9": "(A56 -> (A55 | -A19))",
        "prover9_expression": "(quality_control_issue(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "Whenever drug X has a quality control issue, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
      },
      "(A56 → A58)": {
        "formal": "(A56 → A58)",
        "prover9": "(A56 -> A58)",
        "prover9_expression": "(quality_control_issue(drug_x) -> batch_recall(drug_x))",
        "natural": "If drug X has a quality control issue, then a batch recall is issued for drug X."
      },
      "(A56 ∨ A57)": {
        "formal": "(A56 ∨ A57)",
        "prover9": "(A56 | A57)",
        "prover9_expression": "(quality_control_issue(drug_x) | contamination_risk(drug_x))",
        "natural": "Either drug X has a quality control issue, or drug X has a contamination risk."
      },
      "(A57 → (A55 ∨ ¬A19))": {
        "formal": "(A57 → (A55 ∨ ¬A19))",
        "prover9": "(A57 -> (A55 | -A19))",
        "prover9_expression": "(contamination_risk(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "Provided that drug X has a contamination risk, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
      },
      "(A58 → (A55 ∨ ¬A19))": {
        "formal": "(A58 → (A55 ∨ ¬A19))",
        "prover9": "(A58 -> (A55 | -A19))",
        "prover9_expression": "(batch_recall(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "In the event that a batch recall is issued for drug X, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
      },
      "(A59 ∨ (A17 ∨ A18))": {
        "formal": "(A59 ∨ (A17 ∨ A18))",
        "prover9": "(A59 | (A17 | A18))",
        "prover9_expression": "(supply_shortage(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
        "natural": "Drug X has a supply shortage, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
      },
      "(A60 → A59)": {
        "formal": "(A60 → A59)",
        "prover9": "(A60 -> A59)",
        "prover9_expression": "(production_halt(drug_x) -> supply_shortage(drug_x))",
        "natural": "Assuming production of drug X is halted, then drug X has a supply shortage."
      },
      "(A60 ∨ A61)": {
        "formal": "(A60 ∨ A61)",
        "prover9": "(A60 | A61)",
        "prover9_expression": "(production_halt(drug_x) | raw_material_shortage(drug_x))",
        "natural": "Either production of drug X is halted, or drug X has a raw material shortage."
      },
      "(A61 → (A17 ∨ A18))": {
        "formal": "(A61 → (A17 ∨ A18))",
        "prover9": "(A61 -> (A17 | A18))",
        "prover9_expression": "(raw_material_shortage(drug_x) -> (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
        "natural": "Should drug X have a raw material shortage, then either a safety profile for drug X is established or efficacy of drug X is demonstrated."
      },
      "(A62 → (A60 → A59))": {
        "formal": "(A62 → (A60 → A59))",
        "prover9": "(A62 -> (A60 -> A59))",
        "prover9_expression": "(manufacturing_audit(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
        "natural": "If a manufacturing audit is conducted for drug X, then if production of drug X is halted, drug X has a supply shortage."
      },
      "(A62 ∨ A63)": {
        "formal": "(A62 ∨ A63)",
        "prover9": "(A62 | A63)",
        "prover9_expression": "(manufacturing_audit(drug_x) | process_validation(drug_x))",
        "natural": "A manufacturing audit is conducted for drug X, or process validation is performed for drug X."
      },
      "(A63 → (A60 → A59))": {
        "formal": "(A63 → (A60 → A59))",
        "prover9": "(A63 -> (A60 -> A59))",
        "prover9_expression": "(process_validation(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
        "natural": "Provided that process validation is performed for drug X, then if production of drug X is halted, drug X has a supply shortage."
      },
      "(A64 ∨ ¬A19)": {
        "formal": "(A64 ∨ ¬A19)",
        "prover9": "(A64 | -A19)",
        "prover9_expression": "(stability_issue(drug_x) | -market_withdrawal(drug_x))",
        "natural": "Drug X has a stability issue, or it is not the case that drug X is withdrawn from the market."
      },
      "(A65 → (A64 ∨ ¬A19))": {
        "formal": "(A65 → (A64 ∨ ¬A19))",
        "prover9": "(A65 -> (A64 | -A19))",
        "prover9_expression": "(shelf_life_reduction(drug_x) -> (stability_issue(drug_x) | -market_withdrawal(drug_x)))",
        "natural": "In case the shelf life of drug X is reduced, then either drug X has a stability issue or it is not the case that drug X is withdrawn from the market."
      },
      "(A66 → A65)": {
        "formal": "(A66 → A65)",
        "prover9": "(A66 -> A65)",
        "prover9_expression": "(storage_requirements(drug_x) -> shelf_life_reduction(drug_x))",
        "natural": "If drug X has storage requirements, then the shelf life of drug X is reduced."
      },
      "(A67 → A66)": {
        "formal": "(A67 → A66)",
        "prover9": "(A67 -> A66)",
        "prover9_expression": "(temperature_sensitive(drug_x) -> storage_requirements(drug_x))",
        "natural": "Whenever drug X is temperature sensitive, then drug X has storage requirements."
      },
      "(A7 ∨ G)": {
        "formal": "(A7 ∨ G)",
        "prover9": "(A7 | G)",
        "prover9_expression": "(has_side_effects(drug_x) | safe_for_use(drug_x))",
        "natural": "Either drug X has side effects, or drug X is safe for use."
      },
      "(A8 → A7)": {
        "formal": "(A8 → A7)",
        "prover9": "(A8 -> A7)",
        "prover9_expression": "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
        "natural": "Provided that drug X has severe side effects, then drug X has side effects."
      },
      "(A8 ∨ A9)": {
        "formal": "(A8 ∨ A9)",
        "prover9": "(A8 | A9)",
        "prover9_expression": "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
        "natural": "Drug X has severe side effects, or drug X has mild side effects."
      },
      "(A9 → A39)": {
        "formal": "(A9 → A39)",
        "prover9": "(A9 -> A39)",
        "prover9_expression": "(mild_side_effects(drug_x) -> requires_monitoring(drug_x))",
        "natural": "Assuming drug X has mild side effects, then drug X requires monitoring."
      },
      "(A9 → G)": {
        "formal": "(A9 → G)",
        "prover9": "(A9 -> G)",
        "prover9_expression": "(mild_side_effects(drug_x) -> safe_for_use(drug_x))",
        "natural": "If drug X has mild side effects, then drug X is safe for use."
      },
      "(¬(A2 → ¬A1) → A4)": {
        "formal": "(¬(A2 → ¬A1) → A4)",
        "prover9": "(-(A2 -> -A1) -> A4)",
        "prover9_expression": "(-(rejected(drug_x) -> -approved(drug_x)) -> requires_clinical_trial(drug_x))",
        "natural": "If it is not the case that if drug X is rejected, then it is not the case that drug X is approved, then drug X requires a clinical trial."
      },
      "(¬(A34 → (A30 ∨ A31)) → A35)": {
        "formal": "(¬(A34 → (A30 ∨ A31)) → A35)",
        "prover9": "(-(A34 -> (A30 | A31)) -> A35)",
        "prover9_expression": "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> profitability_decline(drug_x))",
        "natural": "Should it not be the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then profitability of drug X declines."
      },
      "(¬(A34 → (A30 ∨ A31)) → ¬A35)": {
        "formal": "(¬(A34 → (A30 ∨ A31)) → ¬A35)",
        "prover9": "(-(A34 -> (A30 | A31)) -> -A35)",
        "prover9_expression": "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> -profitability_decline(drug_x))",
        "natural": "If it is not the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then it is not the case that profitability of drug X declines."
      },
      "(¬(A4 → A5) → A6)": {
        "formal": "(¬(A4 → A5) → A6)",
        "prover9": "(-(A4 -> A5) -> A6)",
        "prover9_expression": "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> clinical_trial_failed(drug_x))",
        "natural": "Provided that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then the clinical trial for drug X has failed."
      },
      "(¬(A4 → A5) → ¬A6)": {
        "formal": "(¬(A4 → A5) → ¬A6)",
        "prover9": "(-(A4 -> A5) -> -A6)",
        "prover9_expression": "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> -clinical_trial_failed(drug_x))",
        "natural": "In the event that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then it is not the case that the clinical trial for drug X has failed."
      },
      "(¬(A41 → (A9 → A39)) → A42)": {
        "formal": "(¬(A41 → (A9 → A39)) → A42)",
        "prover9": "(-(A41 -> (A9 -> A39)) -> A42)",
        "prover9_expression": "(-(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x))) -> safety_concerns(drug_x))",
        "natural": "Assuming it is not the case that if drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring, then there are safety concerns for drug X."
      },
      "(¬(A44 → (¬(A9 → G) → A10)) → A45)": {
        "formal": "(¬(A44 → (¬(A9 → G) → A10)) → A45)",
        "prover9": "(-(A44 -> (-(A9 -> G) -> A10)) -> A45)",
        "prover9_expression": "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))",
        "natural": "If it is not the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
      },
      "(¬(A44 → (¬(A9 → G) → A10)) → ¬A45)": {
        "formal": "(¬(A44 → (¬(A9 → G) → A10)) → ¬A45)",
        "prover9": "(-(A44 -> (-(A9 -> G) -> A10)) -> -A45)",
        "prover9_expression": "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> -data_integrity_issue(drug_x))",
        "natural": "Should it not be the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then it is not the case that drug X has a data integrity issue."
      },
      "(¬(A9 → G) → A10)": {
        "formal": "(¬(A9 → G) → A10)",
        "prover9": "(-(A9 -> G) -> A10)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))",
        "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
      },
      "(¬(A9 → G) → A11)": {
        "formal": "(¬(A9 → G) → A11)",
        "prover9": "(-(A9 -> G) -> A11)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x))",
        "natural": "Provided that the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
      },
      "(¬(A9 → G) → A49)": {
        "formal": "(¬(A9 → G) → A49)",
        "prover9": "(-(A9 -> G) -> A49)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> restricted_distribution(drug_x))",
        "natural": "In case the absence of mild side effects does not imply drug X is safe for use, then drug X has restricted distribution."
      },
      "(¬(A9 → G) → A50)": {
        "formal": "(¬(A9 → G) → A50)",
        "prover9": "(-(A9 -> G) -> A50)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x))",
        "natural": "Whenever the absence of mild side effects does not imply drug X is safe for use, then drug X requires special handling."
      },
      "(¬(A9 → G) → ¬A10)": {
        "formal": "(¬(A9 → G) → ¬A10)",
        "prover9": "(-(A9 -> G) -> -A10)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -requires_warning_label(drug_x))",
        "natural": "If the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X requires a warning label."
      },
      "(¬(A9 → G) → ¬A49)": {
        "formal": "(¬(A9 → G) → ¬A49)",
        "prover9": "(-(A9 -> G) -> -A49)",
        "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -restricted_distribution(drug_x))",
        "natural": "Assuming the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X has restricted distribution."
      },
      "(¬A25 → A26)": {
        "formal": "(¬A25 → A26)",
        "prover9": "(-A25 -> A26)",
        "prover9_expression": "(-patent_protected(drug_x) -> generic_available(drug_x))",
        "natural": "Should it not be the case that drug X is patent protected, then a generic version of drug X is available."
      },
      "(¬A25 → A27)": {
        "formal": "(¬A25 → A27)",
        "prover9": "(-A25 -> A27)",
        "prover9_expression": "(-patent_protected(drug_x) -> exclusive_marketing(drug_x))",
        "natural": "If it is not the case that drug X is patent protected, then drug X has exclusive marketing rights."
      },
      "(¬A25 → ¬A26)": {
        "formal": "(¬A25 → ¬A26)",
        "prover9": "(-A25 -> -A26)",
        "prover9_expression": "(-patent_protected(drug_x) -> -generic_available(drug_x))",
        "natural": "Provided that it is not the case that drug X is patent protected, then it is not the case that a generic version of drug X is available."
      },
      "(¬A51 → A52)": {
        "formal": "(¬A51 → A52)",
        "prover9": "(-A51 -> A52)",
        "prover9_expression": "(-controlled_substance(drug_x) -> prescription_required(drug_x))",
        "natural": "In the event that it is not the case that drug X is a controlled substance, then a prescription is required for drug X."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-safe_for_use(drug_x) -> approved(drug_x))",
        "natural": "If it is not the case that drug X is safe for use, then drug X is approved."
      },
      "A25": {
        "formal": "A25",
        "prover9": "A25",
        "prover9_expression": "patent_protected(drug_x)",
        "natural": "Drug X is patent protected."
      },
      "A48": {
        "formal": "A48",
        "prover9": "A48",
        "prover9_expression": "compliance_certified(drug_x)",
        "natural": "Drug X is compliance certified."
      },
      "A51": {
        "formal": "A51",
        "prover9": "A51",
        "prover9_expression": "controlled_substance(drug_x)",
        "natural": "Drug X is a controlled substance."
      },
      "A65": {
        "formal": "A65",
        "prover9": "A65",
        "prover9_expression": "shelf_life_reduction(drug_x)",
        "natural": "The shelf life of drug X is reduced."
      },
      "A66": {
        "formal": "A66",
        "prover9": "A66",
        "prover9_expression": "storage_requirements(drug_x)",
        "natural": "Drug X has storage requirements."
      },
      "A67": {
        "formal": "A67",
        "prover9": "A67",
        "prover9_expression": "temperature_sensitive(drug_x)",
        "natural": "Drug X is temperature sensitive."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "safe_for_use(drug_x)",
        "natural": "Drug X is safe for use."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-approved(drug_x)",
        "natural": "It is not the case that drug X is approved."
      },
      "¬A12": {
        "formal": "¬A12",
        "prover9": "-A12",
        "prover9_expression": "-fast_track_approval(drug_x)",
        "natural": "It is not the case that drug X receives fast track approval."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-market_withdrawal(drug_x)",
        "natural": "It is not the case that drug X is withdrawn from the market."
      },
      "¬A20": {
        "formal": "¬A20",
        "prover9": "-A20",
        "prover9_expression": "-voluntary_recall(drug_x)",
        "natural": "It is not the case that drug X is voluntarily recalled."
      },
      "¬A21": {
        "formal": "¬A21",
        "prover9": "-A21",
        "prover9_expression": "-regulatory_violation(drug_x)",
        "natural": "It is not the case that drug X has a regulatory violation."
      },
      "¬A32": {
        "formal": "¬A32",
        "prover9": "-A32",
        "prover9_expression": "-competitive_market_entry(drug_x)",
        "natural": "It is not the case that competitive market entry occurs for drug X."
      },
      "¬A36": {
        "formal": "¬A36",
        "prover9": "-A36",
        "prover9_expression": "-orphan_drug_status(drug_x)",
        "natural": "It is not the case that drug X has orphan drug status."
      },
      "¬A4": {
        "formal": "¬A4",
        "prover9": "-A4",
        "prover9_expression": "-requires_clinical_trial(drug_x)",
        "natural": "It is not the case that drug X requires a clinical trial."
      },
      "¬A42": {
        "formal": "¬A42",
        "prover9": "-A42",
        "prover9_expression": "-safety_concerns(drug_x)",
        "natural": "It is not the case that there are safety concerns for drug X."
      },
      "¬A5": {
        "formal": "¬A5",
        "prover9": "-A5",
        "prover9_expression": "-clinical_trial_completed(drug_x)",
        "natural": "It is not the case that the clinical trial for drug X is completed."
      },
      "¬A52": {
        "formal": "¬A52",
        "prover9": "-A52",
        "prover9_expression": "-prescription_required(drug_x)",
        "natural": "It is not the case that a prescription is required for drug X."
      },
      "¬A55": {
        "formal": "¬A55",
        "prover9": "-A55",
        "prover9_expression": "-manufacturing_defect(drug_x)",
        "natural": "It is not the case that drug X has a manufacturing defect."
      },
      "¬A59": {
        "formal": "¬A59",
        "prover9": "-A59",
        "prover9_expression": "-supply_shortage(drug_x)",
        "natural": "It is not the case that drug X has a supply shortage."
      },
      "¬A64": {
        "formal": "¬A64",
        "prover9": "-A64",
        "prover9_expression": "-stability_issue(drug_x)",
        "natural": "It is not the case that drug X has a stability issue."
      },
      "¬A7": {
        "formal": "¬A7",
        "prover9": "-A7",
        "prover9_expression": "-has_side_effects(drug_x)",
        "natural": "It is not the case that drug X has side effects."
      }
    }
  }
}